McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23

December 12, 2011 1:47 PM | 8 seconds read |
McNicoll Lewis & Vlak has raised the price target on AMAG Pharmaceuticals AMAG to $23 and maintains its Buy rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetIntraday UpdateAnalyst Ratingsmcnicoll lewis vlak
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!